Abstract:Objective: Our objective was to evaluate serum phosphorus control in patients undergoing continuous ambulatory peritoneal dialysis, with and without residual renal function, by investigating the metabolic balance of phosphorus.Methods: We assessed serum phosphorus levels in 205 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The clinical factors related to serum phosphorus were also examined, including dietary phosphate intake, dietary protein intake (DPI), phosphate removal through urine and dialysate, doses of phosphorus binder and vitamin D, and serum intact parathyroid hormone (PTH) levels. Nutritional indexes, including serum albumin (Alb), lean body mass (LBM), hand-grip strength (HGS), and subjective global assessment (SGA), were also assessed. Dialysis adequacy and residual renal function (RRF) were calculated by a standard technique. Patients with RRF <2 mL/min were viewed as having no significant RRF Hyperphosphatemia was diagnosed in patients with serum phosphorus levels >1.78 mmol/L.Results: The mean serum phosphorus level of all patients was 1.6 +/- 0.5 mmol/L (mean +/- SD). Only 58 of 205 patients (28%) had hyperphosphatemia. The average DPI was 0.8 +/- 0.3 g/kg/d, whereas the average dietary phosphorus intake was 691 +/- 201 mg/d. There were no differences in mean serum phosphorus levels or incidents of hyperphosphatemia between patients with and without RRF (1.6 +/- 0.4 mmol/L vs. 1.7 +/- 0.5 mmol/L, P = .256; 22% vs. 31%, P = .336). Although total phosphorus removal through urine and dialysate was lower in the 115 patients without RRF than in the 90 patients with RRF (270 +/- 106 mg vs. 333 +/- 129 mg, P = .000), they simultaneously had a lower dietary phosphorus intake (656 +/- 191 mg vs. 713 +/- 215 mg, P = .046). In addition, patients without RRF had significantly lower DPI, Alb, LBM, and right HGS levels than patients with RRF (P < .01-.05). In those without RRF, the 79 patients without hyperphosphatemia had significantly lower DPI, LBM, and HGS levels, and a higher prevalence of malnutrition diagnosed by SGA, than the 36 patients with hyperphosphatemia (P < .001-.05). However, in patients with RRF, there was no difference in nutritional index between patients with and without hyperphosphatemia (P > .05).Conclusion: A relatively lower prevalence of hyperphosphatemia existed in CAPD patients both with and without RRF, which may be associated with incremental dialysis, the correct administration of phosphorus binder, and a lower protein and phosphorus intake. However, patients without RRF, especially those without hyperphosphatemia, ran the risk of malnutrition, despite a well-controlled phosphorus intake. (C) 2007 by the National Kidney Foundation, Inc.

Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study

[Is the preparation with sodium phosphate purgative for bowel cleansing safe in low-risk patients?]

Acute phosphate nephropathy induced by sodium phosphates oral solution

Evaluation of a Novel Enteral Phosphorus Therapy with Enteral Nutrition during a National Intravenous Sodium Phosphate Shortage

Comprehensive analysis of sodium polystyrene sulfonate-induced colitis: A systematic review

Prospective randomized comparison of oral sodium phosphate and polyethylene glycol lavage for colonoscopy preparation

Comparing reduced-dose sodium phosphate tablets to 2 L of polyethylene glycol: A randomized study

Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: a systematic review and meta-analysis of randomized clinical trials

Outcomes associated to serum phosphate levels in patients with suspected acute coronary syndrome.

Randomized controlled trial of sodium phosphate tablets vs polyethylene glycol solution for colonoscopy bowel cleansing

High-phosphorus diet controlled for sodium elevates blood pressure in healthy adults via volume expansion

Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.

Protocol for the detection and nutritional management of high-output stomas

The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients

Low Prevalence of Hyperphosphatemia Independent of Residual Renal Function in Peritoneal Dialysis Patients

Transient alterations in plasma sodium concentrations with NER1006 bowel preparation: an analysis of three phase III, randomized clinical trials

Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation

Full-Scale Clinical Data and Reshaped Intestinal Microbiome on a Short-Term Low-Phosphorus Diet among Healthy Adults

Intravenous ferric carboxymaltose is associated with lowering of plasma phosphate levels in patients with gastric bypass surgery: a retrospective case series

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis

Effect of Short-Term Low-Protein Diet Supplemented with Keto Acids on Hyperphosphatemia in Maintenance Hemodialysis Patients